Advertisement
Advertisement

GKOS

GKOS logo

Glaukos Corporation

112.53
USD
Sponsored
-0.99
-0.87%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

112.56

+0.03
+0.03%

GKOS Earnings Reports

Positive Surprise Ratio

GKOS beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report
Feb 17, 2026
Estimate for Q4 25 (Revenue/ EPS)
$138.61M
/
-$0.20
Implied change from Q3 25 (Revenue/ EPS)
+3.80%
/
+25.00%
Implied change from Q4 24 (Revenue/ EPS)
+31.38%
/
-50.00%

Glaukos Corporation earnings per share and revenue

On Oct 29, 2025, GKOS reported earnings of -0.16 USD per share (EPS) for Q3 25, beating the estimate of -0.26 USD, resulting in a 39.14% surprise. Revenue reached 133.54 million, compared to an expected 124.99 million, with a 6.84% difference. The market reacted with a +13.89% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 138.61 million USD, implying an increase of 25.00% EPS, and increase of 3.80% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
FAQ
For Q3 2025, Glaukos Corporation reported EPS of -$0.16, beating estimates by 39.14%, and revenue of $133.54M, 6.84% above expectations.
The stock price moved up 13.89%, changed from $77.09 before the earnings release to $87.80 the day after.
The next earning report is scheduled for Feb 17, 2026.
Based on 18 analysts, Glaukos Corporation is expected to report EPS of -$0.20 and revenue of $138.61M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement